Last 12 months
Inside the activity.
3 purchase rows · 10 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 3 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 8 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 17, 2025 Filed Apr 18, 2025 19:51 UTC |
Miller MaryChief Legal Officer
|
Tax withholdingCommon Stock | 558 | $1.81 | $1,009.98 |
DisclosureSEC source: 0000905148-25-001257 · form4.xml · nonDerivative · entry 1 Miller Mary · CIK 0001841088 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,507 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:32 UTC |
Miller MaryChief Legal Officer
|
GrantStock Option (Right to Buy) · Derivative | 15,616 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0000905148-25-001076 · form4.xml · derivative · entry 1 Miller Mary · CIK 0001841088 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,616 Underlying: Common Stock · 15,616 shares Expires 2035-03-31 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on April 1, 2026, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:30 UTC |
Levy Adam D.Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 35,209 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0000905148-25-001075 · form4.xml · derivative · entry 1 Levy Adam D. · CIK 0002061876 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,209 Underlying: Common Stock · 35,209 shares Expires 2035-03-31 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on April 1, 2026, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 22:36 UTC |
Peterson KatharineChief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 31,900 | $0.00 Strike: $5.31 | $0.00 |
DisclosureSEC source: 0000905148-25-000842 · form4.xml · derivative · entry 1 Peterson Katharine · CIK 0002022214 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,900 Underlying: Common Stock · 31,900 shares Expires 2035-02-28 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on March 1, 2026, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 17:13 UTC |
Cuillerot Jean-MarieChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 78,078 | $0.00 Strike: $5.31 | $0.00 |
DisclosureSEC source: 0000905148-25-000831 · form4.xml · derivative · entry 1 Cuillerot Jean-Marie · CIK 0001696108 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,078 Underlying: Common Stock · 78,078 shares Expires 2035-02-28 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on March 1, 2026, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 22:31 UTC |
Miller MaryChief Legal Officer
|
GrantStock Option (Right to Buy) · Derivative | 93,693 | $0.00 Strike: $5.31 | $0.00 |
DisclosureSEC source: 0000905148-25-000840 · form4.xml · derivative · entry 1 Miller Mary · CIK 0001841088 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,693 Underlying: Common Stock · 93,693 shares Expires 2035-02-28 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on March 1, 2026, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 22:28 UTC |
Holm-Jorgensen RasmusChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 109,309 | $0.00 Strike: $5.31 | $0.00 |
DisclosureSEC source: 0000905148-25-000838 · form4.xml · derivative · entry 1 Holm-Jorgensen Rasmus · CIK 0001950496 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,309 Underlying: Common Stock · 109,309 shares Expires 2035-02-28 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on March 1, 2026, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 22:24 UTC |
Gamelin ErickChief Development Officer
|
GrantStock Option (Right to Buy) · Derivative | 78,078 | $0.00 Strike: $5.31 | $0.00 |
DisclosureSEC source: 0000905148-25-000836 · form4.xml · derivative · entry 1 Gamelin Erick · CIK 0001950551 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,078 Underlying: Common Stock · 78,078 shares Expires 2035-02-28 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on March 1, 2026, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 22:21 UTC |
Devroe EricChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 140,540 | $0.00 Strike: $5.31 | $0.00 |
DisclosureSEC source: 0000905148-25-000834 · form4.xml · derivative · entry 1 Devroe Eric · CIK 0001950573 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,540 Underlying: Common Stock · 140,540 shares Expires 2035-02-28 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on March 1, 2026, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 22:11 UTC |
Blume-Jensen PeterDirector · President and CEO
Masson KristinaDirector · EVP - Business Operations
|
GrantStock Option (Right to Buy) · Derivative | 140,540 | $0.00 Strike: $5.31 | $0.00 |
DisclosureSEC source: 0000905148-25-000828 · form4.xml · derivative · entry 2 Blume-Jensen Peter · CIK 0001950499 · Director · President and CEO Masson Kristina · CIK 0001950501 · Director · EVP - Business Operations Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 140,540 Underlying: Common Stock · 140,540 shares Expires 2035-02-28 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on March 1, 2026, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date. F3 · ownership.nature: These securities are held by co-founder and EVP, Dr. Kristina Masson, who is also Dr. Blume-Jensen's spouse. Dr. Blume-Jensen disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 22:11 UTC |
Blume-Jensen PeterDirector · President and CEO
Masson KristinaDirector · EVP - Business Operations
|
GrantStock Option (Right to Buy) · Derivative | 390,390 | $0.00 Strike: $5.31 | $0.00 |
DisclosureSEC source: 0000905148-25-000828 · form4.xml · derivative · entry 1 Blume-Jensen Peter · CIK 0001950499 · Director · President and CEO Masson Kristina · CIK 0001950501 · Director · EVP - Business Operations Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 390,390 Underlying: Common Stock · 390,390 shares Expires 2035-02-28 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on March 1, 2026, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date. F2 · ownership.direct: These securities are held by President and CEO, Dr. Peter Blume-Jensen, who is also Dr. Kristina Masson's spouse. Dr. Masson disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 21:09 UTC |
Blume-Jensen PeterDirector · President and CEO
Masson KristinaDirector · EVP - Business Operations
|
Tax withholdingCommon Stock | 19,904 | $5.54 | $110,268.16 |
DisclosureSEC source: 0000905148-25-000764 · form4.xml · nonDerivative · entry 1 Blume-Jensen Peter · CIK 0001950499 · Director · President and CEO Masson Kristina · CIK 0001950501 · Director · EVP - Business Operations Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,285,781 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. F2 · ownership.direct: These securities are held by President and CEO, Dr. Peter Blume-Jensen, who is also Dr. Kristina Masson's spouse. Dr. Masson disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 22:00 UTC |
Peterson KatharineChief Accounting Officer
|
Tax withholdingCommon Stock | 116 | $5.42 | $628.72 |
DisclosureSEC source: 0000905148-25-000730 · form4.xml · nonDerivative · entry 1 Peterson Katharine · CIK 0002022214 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,419 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 21:59 UTC |
Miller MaryChief Legal Officer
|
Tax withholdingCommon Stock | 217 | $5.42 | $1,176.14 |
DisclosureSEC source: 0000905148-25-000729 · form4.xml · nonDerivative · entry 1 Miller Mary · CIK 0001841088 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,065 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 21:55 UTC |
Holm-Jorgensen RasmusChief Financial Officer
|
Tax withholdingCommon Stock | 434 | $5.42 | $2,352.28 |
DisclosureSEC source: 0000905148-25-000728 · form4.xml · nonDerivative · entry 1 Holm-Jorgensen Rasmus · CIK 0001950496 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,088 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 21:54 UTC |
Gamelin ErickChief Development Officer
|
Tax withholdingCommon Stock | 469 | $5.42 | $2,541.98 |
DisclosureSEC source: 0000905148-25-000727 · form4.xml · nonDerivative · entry 1 Gamelin Erick · CIK 0001950551 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,492 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 21:53 UTC |
Devroe EricChief Operating Officer
|
Tax withholdingCommon Stock | 724 | $5.42 | $3,924.08 |
DisclosureSEC source: 0000905148-25-000726 · form4.xml · nonDerivative · entry 1 Devroe Eric · CIK 0001950573 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,147 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 21:52 UTC |
Blume-Jensen PeterDirector · President and CEO
Masson KristinaDirector · EVP - Business Operations
|
Tax withholdingCommon Stock | 579 | $5.42 | $3,138.18 |
DisclosureSEC source: 0000905148-25-000725 · form4.xml · nonDerivative · entry 2 Blume-Jensen Peter · CIK 0001950499 · Director · President and CEO Masson Kristina · CIK 0001950501 · Director · EVP - Business Operations Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 316,177 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. F3 · ownership.nature: These securities are held by co-founder and EVP, Dr. Kristina Masson, who is also Dr. Blume-Jensen's spouse. Dr. Blume-Jensen disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 21:52 UTC |
Blume-Jensen PeterDirector · President and CEO
Masson KristinaDirector · EVP - Business Operations
|
Tax withholdingCommon Stock | 37,152 | $5.42 | $201,363.84 |
DisclosureSEC source: 0000905148-25-000725 · form4.xml · nonDerivative · entry 1 Blume-Jensen Peter · CIK 0001950499 · Director · President and CEO Masson Kristina · CIK 0001950501 · Director · EVP - Business Operations Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,305,685 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. F2 · ownership.direct: These securities are held by President and CEO, Dr. Peter Blume-Jensen, who is also Dr. Kristina Masson's spouse. Dr. Masson disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein. Read SEC document |
| January 17, 2025 Filed Jan 22, 2025 21:15 UTC |
Miller MaryChief Legal Officer
|
Tax withholdingCommon Stock | 659 | $5.78 | $3,809.02 |
DisclosureSEC source: 0000905148-25-000168 · form4.xml · nonDerivative · entry 1 Miller Mary · CIK 0001841088 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,282 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. Read SEC document |
| November 21, 2024 Filed Nov 25, 2024 21:29 UTC |
Blume-Jensen PeterDirector · President and CEO
Masson KristinaDirector · EVP - Business Operations
|
Tax withholdingCommon Stock | 19,910 | $6.44 | $128,220.40 |
DisclosureSEC source: 0000905148-24-003270 · form4.xml · nonDerivative · entry 1 Blume-Jensen Peter · CIK 0001950499 · Director · President and CEO Masson Kristina · CIK 0001950501 · Director · EVP - Business Operations Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,342,837 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. F2 · ownership.direct: These securities are held by President and CEO, Dr. Peter Blume-Jensen, who is also Dr. Kristina Masson's spouse. Dr. Masson disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein. Read SEC document |
| November 14, 2024 Filed Nov 18, 2024 21:32 UTC |
Peterson KatharineChief Accounting Officer
|
Tax withholdingCommon Stock | 99 | $7.92 | $784.08 |
DisclosureSEC source: 0000905148-24-003228 · form4.xml · nonDerivative · entry 1 Peterson Katharine · CIK 0002022214 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,535 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. Read SEC document |
| November 14, 2024 Filed Nov 18, 2024 21:31 UTC |
Miller MaryChief Legal Officer
|
Tax withholdingCommon Stock | 184 | $7.92 | $1,457.28 |
DisclosureSEC source: 0000905148-24-003227 · form4.xml · nonDerivative · entry 1 Miller Mary · CIK 0001841088 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,941 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. Read SEC document |
| November 14, 2024 Filed Nov 18, 2024 21:30 UTC |
Holm-Jorgensen RasmusChief Financial Officer
|
Tax withholdingCommon Stock | 368 | $7.92 | $2,914.56 |
DisclosureSEC source: 0000905148-24-003226 · form4.xml · nonDerivative · entry 1 Holm-Jorgensen Rasmus · CIK 0001950496 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,522 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. Read SEC document |
| November 14, 2024 Filed Nov 18, 2024 21:29 UTC |
Gamelin ErickChief Development Officer
|
Tax withholdingCommon Stock | 402 | $7.92 | $3,183.84 |
DisclosureSEC source: 0000905148-24-003225 · form4.xml · nonDerivative · entry 1 Gamelin Erick · CIK 0001950551 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,961 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. Read SEC document |
| November 14, 2024 Filed Nov 18, 2024 21:28 UTC |
Devroe EricChief Operating Officer
|
Tax withholdingCommon Stock | 613 | $7.92 | $4,854.96 |
DisclosureSEC source: 0000905148-24-003224 · form4.xml · nonDerivative · entry 1 Devroe Eric · CIK 0001950573 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,871 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. Read SEC document |
| November 14, 2024 Filed Nov 18, 2024 21:26 UTC |
Blume-Jensen PeterDirector · President and CEO
Masson KristinaDirector · EVP - Business Operations
|
Tax withholdingCommon Stock | 490 | $7.92 | $3,880.80 |
DisclosureSEC source: 0000905148-24-003223 · form4.xml · nonDerivative · entry 2 Blume-Jensen Peter · CIK 0001950499 · Director · President and CEO Masson Kristina · CIK 0001950501 · Director · EVP - Business Operations Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 316,756 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. F3 · ownership.nature: These securities are held by co-founder and EVP, Dr. Kristina Masson, who is also Dr. Blume-Jensen's spouse. Dr. Blume-Jensen disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| November 14, 2024 Filed Nov 18, 2024 21:26 UTC |
Blume-Jensen PeterDirector · President and CEO
Masson KristinaDirector · EVP - Business Operations
|
Tax withholdingCommon Stock | 59,766 | $7.92 | $473,346.72 |
DisclosureSEC source: 0000905148-24-003223 · form4.xml · nonDerivative · entry 1 Blume-Jensen Peter · CIK 0001950499 · Director · President and CEO Masson Kristina · CIK 0001950501 · Director · EVP - Business Operations Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,362,747 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. F2 · ownership.direct: These securities are held by President and CEO, Dr. Peter Blume-Jensen, who is also Dr. Kristina Masson's spouse. Dr. Masson disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein. Read SEC document |
| October 17, 2024 Filed Oct 21, 2024 20:22 UTC |
Miller MaryChief Legal Officer
|
Tax withholdingCommon Stock | 558 | $7.87 | $4,391.46 |
DisclosureSEC source: 0000905148-24-002773 · form4.xml · nonDerivative · entry 1 Miller Mary · CIK 0001841088 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,125 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 22:49 UTC |
Miller MaryChief Legal Officer
|
Tax withholdingCommon Stock | 284 | $6.98 | $1,982.32 |
DisclosureSEC source: 0000905148-24-002637 · form4.xml · nonDerivative · entry 1 Miller Mary · CIK 0001841088 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,683 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:11 UTC |
Blume-Jensen PeterDirector · President and CEO
Masson KristinaDirector · EVP - Business Operations
|
Tax withholdingCommon Stock | 79,616 | $9.19 | $731,671.04 |
DisclosureSEC source: 0000905148-24-002335 · form4.xml · nonDerivative · entry 1 Blume-Jensen Peter · CIK 0001950499 · Director · President and CEO Masson Kristina · CIK 0001950501 · Director · EVP - Business Operations Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,422,513 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. F2 · ownership.direct: These securities are held by President and CEO, Dr. Peter Blume-Jensen, who is also Dr. Kristina Masson's spouse. Dr. Masson disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein. Read SEC document |
| August 14, 2024 Filed Aug 16, 2024 20:53 UTC |
Peterson KatharineChief Accounting Officer
|
Tax withholdingCommon Stock | 99 | $7.02 | $694.98 |
DisclosureSEC source: 0000905148-24-002283 · form4.xml · nonDerivative · entry 1 Peterson Katharine · CIK 0002022214 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,634 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. Read SEC document |
| August 14, 2024 Filed Aug 16, 2024 20:52 UTC |
Miller MaryChief Legal Officer
|
Tax withholdingCommon Stock | 184 | $7.02 | $1,291.68 |
DisclosureSEC source: 0000905148-24-002282 · form4.xml · nonDerivative · entry 1 Miller Mary · CIK 0001841088 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,967 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. Read SEC document |
| August 14, 2024 Filed Aug 16, 2024 20:52 UTC |
Masson KristinaDirector · EVP - Business Operations
|
Tax withholdingCommon Stock | 490 | $7.02 | $3,439.80 |
DisclosureSEC source: 0000905148-24-002281 · form4.xml · nonDerivative · entry 1 Masson Kristina · CIK 0001950501 · Director · EVP - Business Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 317,246 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. Read SEC document |
| August 14, 2024 Filed Aug 16, 2024 20:51 UTC |
Holm-Jorgensen RasmusChief Financial Officer
|
Tax withholdingCommon Stock | 368 | $7.02 | $2,583.36 |
DisclosureSEC source: 0000905148-24-002280 · form4.xml · nonDerivative · entry 1 Holm-Jorgensen Rasmus · CIK 0001950496 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,890 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. Read SEC document |
| August 14, 2024 Filed Aug 16, 2024 20:50 UTC |
Gamelin ErickChief Development Officer
|
Tax withholdingCommon Stock | 402 | $7.02 | $2,822.04 |
DisclosureSEC source: 0000905148-24-002279 · form4.xml · nonDerivative · entry 1 Gamelin Erick · CIK 0001950551 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,363 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. Read SEC document |
| August 14, 2024 Filed Aug 16, 2024 20:48 UTC |
Devroe EricChief Operating Officer
|
Tax withholdingCommon Stock | 613 | $7.02 | $4,303.26 |
DisclosureSEC source: 0000905148-24-002278 · form4.xml · nonDerivative · entry 1 Devroe Eric · CIK 0001950573 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,484 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. Read SEC document |
| August 14, 2024 Filed Aug 16, 2024 20:47 UTC |
Blume-Jensen PeterDirector · President and CEO
|
Tax withholdingCommon Stock | 59,765 | $7.02 | $419,550.30 |
DisclosureSEC source: 0000905148-24-002277 · form4.xml · nonDerivative · entry 1 Blume-Jensen Peter · CIK 0001950499 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,502,129 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. Read SEC document |
| July 17, 2024 Filed Jul 19, 2024 20:20 UTC |
Miller MaryChief Legal Officer
|
Tax withholdingCommon Stock | 558 | $7.69 | $4,291.02 |
DisclosureSEC source: 0001140361-24-033600 · form4.xml · nonDerivative · entry 1 Miller Mary · CIK 0001841088 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,151 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 21:36 UTC |
RA CAPITAL MANAGEMENT, L.P.Director · 10% owner
RA Capital Healthcare Fund LPDirector · 10% owner
RA Capital Nexus Fund II, L.P.Director
Kolchinsky PeterDirector · 10% owner
Shah Rajeev M.Director · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 20,275 | $0.00 Strike: $6.52 | $0.00 |
DisclosureSEC source: 0001415889-24-018035 · form4-06242024_090612.xml · derivative · entry 1 RA CAPITAL MANAGEMENT, L.P. · CIK 0001346824 · Director · 10% owner RA Capital Healthcare Fund LP · CIK 0001315082 · Director · 10% owner RA Capital Nexus Fund II, L.P. · CIK 0001825376 · Director Kolchinsky Peter · CIK 0001384859 · Director · 10% owner Shah Rajeev M. · CIK 0001619841 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 20,275 Underlying: Common Stock · 20,275 shares Expires 2034-06-19 F1 · derivative.exercise_date: The shares subject to the option shall vest on the date immediately preceding the date of the Issuer's next annual meeting of stockholders, subject to Dr. Derek DiRocco's continuous service through each applicable vesting date. F2 · ownership.nature: RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus Fund II, L.P. (the "Nexus Fund II"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, the Nexus Fund II, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein. F3 · ownership.nature: Derek DiRocco is a Partner of the Adviser who serves on the Issuer's board of directors. Under Dr. DiRocco's arrangement with the Adviser, Dr. DiRocco holds the option for the benefit of the Fund and the Nexus Fund II. Dr. DiRocco is obligated to turn over to the Adviser any net cash or stock received upon exercise of the option, which will offset advisory fees owed by the Fund and the Nexus Fund II to the Adviser. The Reporting Persons therefore disclaim beneficial ownership of the option and underlying common stock. Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 21:28 UTC |
TOMSICEK MICHAEL JOHNDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,275 | $0.00 Strike: $6.52 | $0.00 |
DisclosureSEC source: 0000905148-24-001777 · form4.xml · derivative · entry 1 TOMSICEK MICHAEL JOHN · CIK 0001570392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,275 Underlying: Common Stock · 20,275 shares Expires 2034-06-19 F1 · derivative.exercise_date: The shares subject to the option shall vest on the date immediately preceding the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 21:26 UTC |
BAUM CHARLES MDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,275 | $0.00 Strike: $6.52 | $0.00 |
DisclosureSEC source: 0000905148-24-001774 · form4.xml · derivative · entry 1 BAUM CHARLES M · CIK 0001579824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,275 Underlying: Common Stock · 20,275 shares Expires 2034-06-19 F1 · derivative.exercise_date: The shares subject to the option shall vest on the date immediately preceding the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 21:27 UTC |
Shacham SharonDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,275 | $0.00 Strike: $6.52 | $0.00 |
DisclosureSEC source: 0000905148-24-001776 · form4.xml · derivative · entry 1 Shacham Sharon · CIK 0001588438 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,275 Underlying: Common Stock · 20,275 shares Expires 2034-06-19 F1 · derivative.exercise_date: The shares subject to the option shall vest on the date immediately preceding the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 21:27 UTC |
DiRocco DerekDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,275 | $0.00 Strike: $6.52 | $0.00 |
DisclosureSEC source: 0000905148-24-001775 · form4.xml · derivative · entry 1 DiRocco Derek · CIK 0001792061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,275 Underlying: Common Stock · 20,275 shares Expires 2034-06-19 F1 · derivative.exercise_date: The shares subject to the option shall vest on the date immediately preceding the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service through each applicable vesting date. F2 · ownership.direct: Under the Reporting Person's arrangement with RA Capital Management, L.P. (the "Adviser"), the Reporting Person holds the stock option for the benefit of RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus Fund II, L.P. (the "Nexus Fund II"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received upon exercise of the stock option, which will offset advisory fees owed by the Fund and the Nexus Fund II. The Reporting Person therefore disclaims beneficial ownership of the stock option and underlying Common Stock. Read SEC document |
| May 17, 2024 Filed May 21, 2024 20:04 UTC |
Devroe EricChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $1.04 | $0.00 |
DisclosureSEC source: 0000905148-24-001566 · form4.xml · derivative · entry 2 Devroe Eric · CIK 0001950573 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,615 Underlying: Common Stock · 10,000 shares Expires 2031-01-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vested on October 5, 2021, and the remaining shares subject to the option vested or shall vest in 12 equal quarterly installments thereafter, in each case subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| May 17, 2024 Filed May 21, 2024 20:04 UTC |
Devroe EricChief Operating Officer
|
Exercise / conversionCommon Stock | 10,000 | $1.04 | $10,400.00 |
DisclosureSEC source: 0000905148-24-001566 · form4.xml · nonDerivative · entry 1 Devroe Eric · CIK 0001950573 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,097 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2024 Filed May 16, 2024 23:05 UTC |
Peterson KatharineChief Accounting Officer
|
Tax withholdingCommon Stock | 99 | $8.36 | $827.64 |
DisclosureSEC source: 0000905148-24-001495 · form4.xml · nonDerivative · entry 1 Peterson Katharine · CIK 0002022214 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,733 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. Read SEC document |
| May 14, 2024 Filed May 16, 2024 23:03 UTC |
Miller MaryChief Legal Officer
|
Tax withholdingCommon Stock | 184 | $8.36 | $1,538.24 |
DisclosureSEC source: 0000905148-24-001493 · form4.xml · nonDerivative · entry 1 Miller Mary · CIK 0001841088 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,709 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. Read SEC document |
| May 14, 2024 Filed May 16, 2024 23:02 UTC |
Masson KristinaDirector · EVP - Business Operations
|
Tax withholdingCommon Stock | 490 | $8.36 | $4,096.40 |
DisclosureSEC source: 0000905148-24-001491 · form4.xml · nonDerivative · entry 1 Masson Kristina · CIK 0001950501 · Director · EVP - Business Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 317,736 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. Read SEC document |
| May 14, 2024 Filed May 16, 2024 23:00 UTC |
Holm-Jorgensen RasmusChief Financial Officer
|
Tax withholdingCommon Stock | 368 | $8.36 | $3,076.48 |
DisclosureSEC source: 0000905148-24-001489 · form4.xml · nonDerivative · entry 1 Holm-Jorgensen Rasmus · CIK 0001950496 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,258 F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.